cyclosporin A microemulsion / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 353 Diseases   93 Trials   93 Trials   3415 News 
114 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporin A microemulsion / Generic mfg.
ACTRN12610000320055: Removal Of Cyclosporine With Everolimus On Inflammation And Vascular Endpoints

Not yet recruiting
4
28
 
Heath Department of Western Australia, Novartis Pharmaceutical Company Pty Ltd, Novartis Pharmaceutical Company Pty Ltd
Cardiovascular risk
 
 
2005-004607-11: Prospective, randomized, long-term study compairing a Neoral (C-0h monitoring)-based steroid-free to an everolimus-myfortic based, calcineurin-inhibitor-free immunosuppressive treatment on graft function and on the long term impact on cardiovascular risk factors after "de novo" kidney transplantation.

Ongoing
4
120
Europe
Myfortic, certican, sodium mycophenolate, Neoral, Capsule*, Myfortic 180 mg, Certican 0.25 mg, Myfortic 360 mg, Certican 0.50 mg, Certican 0.75 mg, Neoral 10 mg, Neoral 25 mg, Neoral 50 mg, Neoral 100 mg
Hopital Erasme
“De novo” renal transplantation
 
 
2005-004460-22: Multicenter, pilot, open, randomized, parallel group study to evaluate the association of Neoral with ACE-inhibitors as compared to corticosteroids with ACE-inhibitors in the treatment of de novo nephrotic syndrome due to focal segmental glomerulosclerosis.

Ongoing
4
50
Europe
Neoral, Medrol, zestril, Capsule*, Tablet, Neoral, Medrol, zestril
Hopital Erasme
focal and segmental glomerulosclerosis
 
 
2005-004469-40: Multicenter, pilot, open, randomized, parallel group study to evaluate the association of Neoral with ACE-inhibitors as compared to ACE-inhibitors alone in the treatment of de novo nephrotic syndrome due to idiopathic membranous glomerulopathy

Ongoing
4
50
Europe
Neoral, zestril, Capsule*, Tablet, Neoral, zestril
Hopital Erasme
Membranous Nephropathy
 
 
2008-000252-28: A Multi-Centre Prospective Controlled Trial Comparing Calcineurin Inhibitor Monotherapy With Sirolimus Monotherapy in Hepatitis C Infected Patients with Hepatic Fibrosis Following Liver Transplantation

Ongoing
4
120
Europe
Neoral, Coated tablet, Capsule, hard, Capsule, soft, Rapamune, Prograf, Neoral
Cambridge University Hospitals NHS Foundation Trust
Patients who have undergone liver transplantation and are infected with Hepatitis C virus.
 
 
ChiCTR-TNC-11001512: Clinical Study of strictly selected patients with myelodysplastic syndrome (MDS) undergoing immunosuppressive therapy (IST)

Completed
4
100
 
One part patients received antithymocyte globulin (ATG) (Fresenius Kabi Pharmaceutical Co., Ltd. Germany.) for 4 days at a dose of 4 mg/kg/day followed by cyclosporine A (Novartis Pharma Schweiz AG) (3~5 mg/kg/day). The remaining patients received cyclosporine treatment only.
Shanghai Sixth People's Hospital; Shanghai Sixth People's Hospital, SHDC12010202
low and intermediary risk MDS
 
 
2005-000707-34: The induction of apoptosis by anti-psoriatic treatments

Ongoing
4
100
Europe
INFLIXIMAB, ETANERCEPT, METHOTREXATE SODIUM TABLETS, CICLOSPORIN A CAPSULES, HYDROXYCARBAMIDE, ACITRETIN, CALCIPOTRIOL, HYDROMOL, SHORT CONTACT DITHRANOL IN HYDROMOL, DITHRANOL IN LASSAR'S PASTE, STRONG COAL TAR SOLUTION IN HYDROMOL, PUVASORALEN-8, Powder for injection*, Powder and solvent for solution for injection, Tablet, Capsule*, Cream, Ointment, REMICADE, ENBREL, METHOTREXATE, NEORAL, HYDREA, NEOTIGASON, DOVONEX CREAM, DOVONEX OINTMENT, HYDROMOL OINTMENT, METHOXSALEN
The Newcastle upon Tyne Hospitals NHS Trust
Psoriasis
 
 
ChiCTR-TRC-14004216: Clinical trial about Cyclosporin A in the prevention and treatment of recurrent spontaneous abortion

Completed
4
60
 
oral Cyclosporin A 50-75mg t.i.d.(q8h) ×20-30days ;oral Dydrogesterone 10mg t.i.d.(q8h) ×20-30days ;oral Cyclosporin A 50-75mg and Dydrogesterone 10mg t.i.d.(q8h) ×20-30days
The Obstetrics & Gynecology Hospital, Fudan University; The Obstetrics & Gynecology Hospital, Fudan University, Hospital funding
recurrent spontaneous abortion
 
 
2004-004488-31: Does cyclosporine A reduce the insulin secretion from the pancreas?

Ongoing
4
16
Europe
Sandimmun Neoral, Sandimmun Neoral, Sandimmun Neoral
Rikshospitalet University Hospital, University of Oslo
Kidney failure / dialysis patients / transplantation
 
 
2005-004299-19: New Possibilities of TDM of Cyclosporine A and its metabolites after kidney transplantation

Ongoing
4
375
Europe
not fixed in the protocol
University Hospital Ostrava
patient on standart immunusupresive therapy with cyclosporine A after renal transplantation
 
 
2005-002266-10: Estudio para comparar la evolución de la hepatitis C con ciclosporina C2 frente a tacrolimus en receptores de trasplante hepático de novo virus C positivos.Study to compare hepatitis C evolution with ciclosporin C2 versus tacrolimus with patients virus C positive who have received a liver transplantation de novo.

Ongoing
4
246
Europe
Sandimmun Neoral, Prograf, FK506, Sandimmun Neoral, Prograf, Sandimmun Neoral, Prograf
Dr. Evaristo Varo Pérez
Trasplante hepático
 
 
2004-004947-23: Efficacité de la rapamycine dans la prévention secondaire des cancers cutanés chez les transplantés rénaux. Etude ouverte randomisée Rapamycine vs anticalcineurines

Ongoing
4
25
Europe
Neoral, Rapamune, neoral, neoral 50MG, Rapamune 1 mg, Neoral 100mg, Rapamune 2 mg, neoral 50MG, Rapamune 1 mg, Neoral 100mg, Rapamune 2 mg
UF de méthodologie en recherche clinique, Hospices Civils de Lyon
To evaluate the impact of two imnosupressive regimens on the incidence of skin cancers among patients who has a first spinocellular skin cancer after renal transplantation
 
 
2005-004509-27: Intérêt de la rapamicine (Rapamune(R)) pour la prévention secondaire des cancers cutanés chez les transplantés rénaux ayant présentant plus d\'un Carcinome Spinocellaire.

Ongoing
4
25
Europe
Neoral, Rapamune, neoral, Neoral 50 mg, rapamune 1mg, Neoral 100 mg, rapamune 2 mg, Neoral 50 mg, rapamune 1mg, Neoral 100 mg, rapamune 2 mg
Cliniques Hopitaux Universitaires NANTES, Hospices Civils de Lyon
To evaluate the impact of two immunosuppressive regimens on the incidence of skin cancers among patients who have had previously a first spinocellulaire skin cancer after transplantation
 
 
2006-004709-24: Mycophenolate sodium (Myfortic®) in the Treatment of Uveitis: a Pilot Study.

Ongoing
4
24
Europe
Myfortic, Neoral, Prednison, Neoral, Neoral
ErasmusMC
Uveitis
 
 
2007-000789-19: Withdrawal of Calcineurin Inhibitors (CNIs) during administration of Mycophenolate Mofetil (MMF) in liver transplant patients suffering adverse effects from CNIs: Study of the reduction in rejection risk by therapeutic drug monitoring of Mycophenolate Mofetil

Ongoing
4
130
Europe
Cellcept, Neoral-Sandimmun, Prograft, Cellcept, Neoral-Sandimmun, Prograft
CHU de Liège, Domaine Universitaire du Sart Tilman
liver transplant patients suffering adverse effects from treatment with calcineurin inhibitors
 
 
2006-002786-39: A PROSPECTIVE TRIAL , MONOCENTRIC, RANDOMIZED, TO EVALUATE THE RENAL\'S FUNCTION IN SUBJECTS WITH CARDIAC TRANSPLANTED

Ongoing
4
200
Europe
CERTICAN*60CPS 0,25MG, SANDIMMUN NEORAL*50CPS 10MG, SANDIMMUN NEORAL*50CPS 25MG, SANDIMMUN NEORAL*50CPS 50MG, SANDIMMUN NEORAL*30CPS 100MG, SANDIMMUN*OS FL 50ML 100MG/ML, CERTICAN*60CPS 0,25MG, SANDIMMUN NEORAL*50CPS 10MG, SANDIMMUN NEORAL*50CPS 25MG, SANDIMMUN NEORAL*50CPS 50MG, SANDIMMUN NEORAL*30CPS 100MG, SANDIMMUN*OS FL 50ML 100MG/ML
AZIENDA OSPEDALIERA \"OSPEDALI RIUNITI DI BERGAMO\" (A.O. DI RILIEVO NAZIONALE)
CARDIAC-TRASPLATED
 
 
2007-003649-34: RENAL RESCUE IMMUNOSUPPRESSION FOLLOWING HEART TRANSPLANTATION

Ongoing
4
56
Europe
Mycophenolic acid, Ciclosporin, Tacrolimus, Azathioprine, Mycophenolate mofetil, Myfortic, Neoral, Prograf, Cellcept, Myfortic, Neoral, Prograf, Cellcept
University Hospital of South Manchester NHS Foundation Trust
Renal impairment following heart transplantation
 
 
2009-014436-38: A prospective, open, randomized, single center study comparing the effects of duo therapy with Everolimus and steroids versus triple treatment of low dose calcineurin inhibitor, low-dose MMF and steroids at least one year after renal transplantation.Effects on renal function, tolerability, chronic allograft damage, cardiovascular parameters and malignancies.

Ongoing
4
130
Europe
Certican, Neoral, Prograft, Mycofenolaat mofetil, Prednisolon 5 PCH, Certican, Neoral, Prograft, Mycofenolaat mofetil CF 500, Prednisolon 5 PCH, Certican, Neoral, Prograft, Mycofenolaat mofetil CF 500, Prednisolon 5 PCH
UMCG
Renal transplantation.
 
 
2007-002420-15: Phase II-Studie zur Effizienz der vorzeitigen Reduktion von CSA/MMF bei fallendem linienspezifischen Chimärismus nach allogener Stammzelltransplantation nach Konditionierung mit low-dose TBI/Fludarabin bei älteren Patienten mit hämatologischen Erkrankungen

Ongoing
4
200
Europe
CellCept, CellCept, Cyclosporin A, CellCept, Cyclosporin A
Universität Leipzig
Effizienz der vorzeitigen Reduktion von CSA/MMF bei fallendem linienspezifischen Chimärismus nach allogener Stammzelltransplantation nach Konditionierung mit low-dose TBI/Fludarabin bei älteren Patienten mit hämatologischen Erkrankungen
 
 
2005-004372-20: A randomised, prospective,open-label, multi-centre study comparing the efficacy and safety of conversion to Sirolimus in stable renal transplant recipients with a cutaneous squamous cell carcinoma.

Ongoing
4
90
Europe
Sirolimus, neoral, ciclosporin, Tacrolimus, Mycophenolate Mofetil, azathioprine, 12,
Oxford Radcliffe Hospitals NHS Trust
Cutaneous squamous cell carcinoma after kidney transplantation
 
 
CTRIPS, ChiCTR-IPR-15005990: Cyclosporine A in the Treatment of Interstitial Pneumonitis associated with Sjogren’s syndrome(): A Prospective, Randomized, Multicenter, Double-Blind Placebo-Controlled Trial

Not yet recruiting
4
240
 
glucocorticoid+CsA ;glucocorticoid+placebo
Peking University People's Hospital; Level of the institution:, Hangzhou China-US East China pharmaceutical Co., Ltd.
Sjogren's syndrome
 
 
ChiCTR-OPN-17013383: Therapeutic Effect And Plasma Concentration Of Cyclosporin A Combined Acitretin For The Treatment Of Psoriasis

Recruiting
4
120
 
acitretin only ;cyclosporin A combined acitretin
Hospital for Skin Diseases, Chinese Academy of Medical Sciences; Hospital for Skin Diseases, Chinese Academy of Medical Sciences, Nanjing pharmaceutical association - Changzhou Siyao Hospital pharmacy institute research fund
Moderate-To-Severe Psoriasis
 
 
2020-002123-11: CLINICAL STUDY IN WHICH PATIENTS ARE RANDOMIZED TO RECEIVE HYDROXYCHLOROQUINE VS. CYCLOSPORINE - HYDROXYCHLOROQUINE TO COMPARE THEIR EFFICACY IN THE TREATMENT OF COVID-19 PNEUMONIA. ESTUDIO CLÍNICO EN EL QUE LOS PACIENTES SON ALEATORIZADOS A RECIBIR HIDROXICLOROQUINA VS. CICLOSPORINA-HIDROXICLOROQUINA PARA COMPARAR SU EFICACIA EN EL TRATAMIENTO DE LA NEUMONIA COVID-19.

Ongoing
4
280
Europe
Capsule, soft, Coated tablet, Sandimmun Neoral 25 mg cápsulas blandas Sandimmun Neoral 50 mg cápsulas blandas Sandimun Neoral 100 mg cápsulas blandas, Dolquine 200 mg comprimidos recubiertos
Tatiana Cobo Ibáñez, Gemma María Mora Ortega, Gonzalo Serralta San Martín, Hospital Universitario Infanta Sofía
COVID-19 PNEUMONIA NEUMONIA COVID-19, COVID-19 PNEUMONIA NEUMONIA COVID-19, Diseases [C] - Virus Diseases [C02]
 
 
ChiCTR1900021757: A randomized controlled trial for hydroxychloroquine sulfate in the treatment of idiopathic membranous nephropathy

Recruiting
4
220
 
Supportive treatment+Perindopril 8 mg/day ;Supportive treatment+Perindopril 8 mg/day+hydroxychloroquine sulfate (200mg 2/d) ;Low dose glucocorticoid (0.5mg/kg.d)+cyclosporine A (valley concentration controlled at 50-100ng/ml) ;Low dose glucocorticoid (0.5mg/kg.d)+cyclosporine A (valley concentration controlled at 50-100ng/ml)+hydroxychloroquine sulfate (200mg 2/d)
Nephrology Division, First Hospital Affiliated to Army Medical University; First Hospital Affiliated to Army Medical University, Training Program for Clinical Research Talents of Army Medical University
Idiopathic Membranous Nephropathy
 
 
CTP/DMILD, ChiCTR1900025087: Cyclosporine A in the treatment of polymyositis /dermatomyositis associated interstitial pulmonary disease: a prospective, opened, multicenter, randomized, controlled clinical study

Not yet recruiting
4
150
 
CsA+glucocorticoid ;CTX+glucocorticoid
Guangdong Provincial People's Hospital; Guangdong Provincial People's Hospital, Guangdong Provincial People's Hospital
Polymyositis/Dermatomyositis associated Interstitial Lung Disease
 
 
NCT02745717: The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia

Completed
4
60
RoW
Thymoglobulin, Thymoglobuline, Cord blood, Cyclosporine Oral Product, cyclosporine A
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Ruijin Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Tongji Hospital, Tongji University School of Medicine, Zhejiang Provincial Hospital of TCM
Severe Aplastic Anemia
12/21
12/21
NCT04376528: Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy

Recruiting
4
89
RoW
Cyclosporin A, Mycophenolate Mofetil
West China Hospital
Hepatitis, Autoimmune, Primary Biliary Cholangitis, Immunosuppression
12/21
12/21
ChiCTR2000040991: Cyclosporine A combined with eltrombopag in the treatment for primary immune thrombocytopenia: a prospective, multicenter, single-arm, open clinical study

Recruiting
4
28
 
Cyclosporine A combined with eltrombopag
The First Affiliated Hospital, College of Medicine, Zhejiang University; The First Affiliated Hospital, College of Medicine, Zhejiang University, self-raised
primary immune thrombocytopenia
 
 
NCT04009525: Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

Completed
4
823
RoW
Busulfan, Bu, Cyclophosphamide, Cy, Fludarabine, Flu, Thymoglobulin, ATG, cyclosporine A, CsA, Mycophenolate mofetil, MMF, Tacrolimus, FK506, Methotrexate, MTX
First Affiliated Hospital of Guangxi Medical University, Peking University People's Hospital, Ruijin Hospital, The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army, LiuZhou People's Hospital, The First People's Hospital of Yunnan, Liuzhou Workers Hospital, Xinqiao Hospital of Chongqing, Affiliated Hospital of Youjiang University of Ethnic Medicine, Hainan People's Hospital, Maoming People's Hospital, Red Cross Hospital of Yulin City, Guilin Medical College, Wuzhou People's Hospital, Guangxi Autonomous Region People's Hospital, The 920th Hospital of Joint Logistics Support Force of People's Liberation Army
Thalassemia Major
07/23
10/23
ChiCTR1900026551: Multiple-center clinical study of pediatric diffuse alveolar hemorrhage in China

Not yet recruiting
4
580
 
Glucocorticoid combined with hydroxychloroquine ;Glucocorticoid combined with azathioprine ;Glucocorticoid combined with methotrexate ;Glucocorticoid combined with cyclosporine A ;Glucocorticoid alone ;Glucocorticoid or combined with immunosuppressive agents
The First Affiliated Hospital of Guangxi Medical Uniersity; The First Affiliated Hospital of Guangxi Medical Uniersity, Self-funding
Diffuse Alveolar Hemorrhage
 
 
ChiCTR2000033267: The auxiliary effect of cyclosporine A in the thrombectomy for acute ischemic stroke: a prospective, single-center, randomized, controlled, open-label, blinded end point trial.

Not yet recruiting
4
38
 
Intravenous injection of cyclosporine A before mechanical thrombectomy (Using the cyclosporine A solution of 250mg/5ml, Prepare injection as required 2.0mg/kg, i.e. 0.04ml/kg.) ;Intravenous injection of normal saline before mechanical thrombectomy (Use 0.9% sodium chloride solution and inject as per 0.04ml/kg).
Shanghai Ninth People's Hospital affiliated to Shanghai Jiaotong University School of Medicine; Shanghai Ninth People's Hospital affiliated to Shanghai Jiaotong University School of Medicine, Self financing
Ischemic stroke
 
 
NCT02144857: Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis

Recruiting
4
200
Europe
etanercept, Enbrel, ustekinumab, Stelara, cyclosporine, Neoral, Secukinumab, Cosentyx, Apremilast, Otezla
University of Athens
Psoriasis
09/23
12/23
DermAtOmics, NCT05692843: Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response

Recruiting
4
100
Europe
Cyclosporin A, Prospective, Follow-up of Cyclospoin treatment already started, Ambispective
Instituto de Investigación Hospital Universitario La Paz
Atopic Dermatitis
11/23
07/24
NCT06525948: Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA

Not yet recruiting
4
54
RoW
rhTPO, Cyclosporin A
Peking Union Medical College Hospital
Aplastic Anemia, Transfusion-dependent Anemia
06/25
12/25
ChiCTR2100046724: Cyclosporine A in the treatment of unexplained recurrent abortion: a prospective, randomized, double-blind, superior efficacy, placebo-controlled, single-center trial

Not yet recruiting
4
132
 
Take cyclosporine oral solution ;Take placebo
Taizhou People's Hospital; Taizhou People's Hospital, Research Funding for Postgraduates
Recurrent abortion of unknown cause
 
 
NCT04239859: Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis

Not yet recruiting
4
40
RoW
secukinumab, Methotrexate, Cyclosporin A, Acitretin
Singapore General Hospital, Translational Immunology Institute
Plaque Psoriasis
12/27
12/27
NCT04537689: Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis

Recruiting
4
40
RoW
Ixekizumab, Methotrexate, Cyclosporin A, Acitretin
Singapore General Hospital, Translational Immunology Institute
Plaque Psoriasis
12/27
12/27
ChiCTR2200057673: The efficacy and safety of cyclosporine in improving pregnancy outcome of patients with repeated embryo implantation failure:An open, randomized, controlled study

Recruiting
4
172
 
Freezing embryo transfer (FET) ;Freezing embryo transfer (FET)+cyclosporin A 50mg bid
Chongqing Health Center For Women And Children; Chongqing Health Center For Women And Children, Hangzhou ZhongMei Huadong Pharmaceutical Co., Ltd.
repeated embryo implantation failure(RIF)
 
 
2009-018174-54: MERIDIAN: A 12-month prospective, open-label, randomized, multicenter,parallel-group study to evaluate the efficacy, safety andtolerability of a Myfortic®-based regimen in the conversion from aCNI to everolimus in de novo transplant recipients of ExpandedCriteria of Donor kidneys

 
3/4
35
Europe
Myfortic, Certican, Sandimmun Neoral, Simulect, ERL080, Myfortic, Certican, Sandimmun Neoral, Simulect, Myfortic, Certican, Sandimmun Neoral, Simulect
Novartis Pharma Services AG, Novartis Farmacéutica, S.A., Novartis Services AG
de novo transplant recipients of Expanded Criteria Donor (ECD) kidneys
 
07/10
2008-001968-36: Comparison of infliximab and ciclosporin in steroid resistant ulcerative colitis: a Trial

Ongoing
3
250
Europe
Concentrate for solution for infusion, Capsule, soft, Remicade, Sandimmun, Neoral Soft Gelatin Capsules
Swansea University
Acute severe steroid resistant ulcerative colitis
 
 
NCT00856466: Extension Study to CRAD001A1202

Active, not recruiting
3
110
Japan
everolimus, mycophenolate mofetil
Novartis
Renal Transplant
12/12
 
2008-000480-41: Multicenter, randomised, double masked, controlled clinical trial on the safety and efficacy of Cyclosporine A eyedrop treatment on patients with ocular cicatricial pemphigoid.

Ongoing
3
84
Europe
RESTASIS, RESTASIS
UNIVERSITA\' CAMPUS BIOMEDICO
Ocular cicatricial pemphigoid (OCP)
 
 
2007-004652-36: Étude randomisée multicentrique de l’efficacité du méthotrexate (MTX) comprimés versus ciclosporine (Cy) capsules dans la dermatite atopique (DA) de forme modérée à sévère de l’adulte

Ongoing
3
100
Europe
METHOTREXATE, CICLOSPORIN, NOVATREX, NEORAL, NOVATREX, NEORAL
HOSPICES CIVILS DE LYON
Dermatite atopique
 
 
2006-006577-25`ACTRN12615000820505: A prospective randomized study comparing rapamune and tacrolimus vs. cyclosporine and methotrexate as immune prophylaxis in allogeneic hematopoietic stem cell transplantation, using HLA-A, -B, -DRB1 identical related or unrelated donors. A Nordic multicenter study.

Ongoing
3
200
Europe
Rapamune, Prograf, Sandimmun Neoral, Methotrexate, Rapamune, Prograf, Sandimmun Neoral, Methotrexate, Rapamune, Prograf, Sandimmun Neoral, Methotrexate
Karolinska Institutet, Nordic Bone Marrow Transplant Group (NBMT), Federation University
Stress, Anxiety, Depression
 
 
2017-004983-37: Multicenter, randomized, prospective study to establish the clinical efficacy and the mechanisms of tolerance following immunosuppression withdrawal in liver transplantation Estudio multicéntrico, aleatorizado, prospectivo, para definir la eficacia clínica y los mecanismos de tolerancia tras la retirada de inmunosupresión en el Trasplante Hepático

Ongoing
3
324
Europe
Ciclosporin, Prednisone, Tacrolimus, Micofenolato Mofetilo, NA, Capsule, soft, Tablet, Capsule, hard, Sandimmun Neoral, Prednisona Kern Pharma, Tacrolimus, CellCept
Fundación para la Formación e Investigación Sanitarias de la Región de Murcia, Instituto de Salud Carlos III
Hepatic transplant Trasplante hepático, People that have undergone an hepatic transplant Personas a las que se les haya trasplantado el hígado., Body processes [G] - Immune system processes [G12]
 
 
2019-002366-12: Adalimumab vs Conventional ImmunoSuppression for Corticosteroid-sparing for Uveitis (ADVISE) Trial

Not yet recruiting
3
222
Europe
Adalimumab, Azathioprine/Imuran, Methotrexate/Rheumatrex, Mycophenolate/mofetil 500mg tablets, Cyclosporine Neoral, Prograf 0.5 mg hard capsules, Mycophenolate mofetil 250mg Capsules, Mycophenolate mofetil 500 mg powder for concentrate for solution for infusion., SANDIMMUN® Concentrate for Solution for Infusion 50mg/ml., EU/1/96/005/002 CellCept, PL 00101/0483 PL 00101/0387-0389, PL 30306/0154, PL 20075/0395, Injection, , Tablet, Capsule, Capsule, hard, Infusion, Adalimumab, Azathioprine/Imuran, Methotrexate/Rheumatrex, Mycophenolate/mofetil 500mg tablets, Cyclosporine Neoral, Prograf 0.5 mg hard capsules, Mycophenolate mofetil 250mg Capsules, Mycophenolate mofetil 500 mg powder for concentrate for solution for infusion., SANDIMMUN® Concentrate for Solution for Infusion 50mg/ml.
Johns Hopkins University
Uveitic macular oedema, Swelling of part of the retina called the macula, which is responsible for fine vision, occuring due to inflammation in the eye (uveitis), Diseases [C] - Eye Diseases [C11]
 
 
2021-002166-40: A Multicenter trial to Assess the Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Estudio multicéntrico para evaluar la seguridad y eficacia del Nemolizumab in pacientes con dermatitis atópica de moderada a severa.

Ongoing
3
270
Europe
Nemolizumab, CD14152, Powder and solution for solution for injection
Galderma S.A., Galderma S.A.
Moderate-to-Severe Atopic Dermatitis Dermatitis atópica de modera a severa, Moderate-to-Severe Atopic Dermatitis Dermatitis atópica de modera a severa, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
2021-003749-39: A 4 week, Phase III, multicenter, double-masked, study to evaluate safety and efficacy of Oxervate® (cenegermin) 20 mcg/mL ophthalmic solution in patients with severe Sjogren’s dry eye disease under treatment with Cyclosporine A. Studio di 4 settimane, di Fase III, multicentrico, in doppio cieco, per valutare la sicurezza e l'efficacia della soluzione oftalmica di Oxervate® (cenegermin) 20 mcg/mL in pazienti affetti da sindrome dell'occhio secco di Sjögren grave in trattamento con Ciclosporina A

Not yet recruiting
3
48
Europe
OXERVATE, [Recombinant Human Nerve Growth Factor (rhNGF)], Eye drops, Oxervate
DOMPé FARMACEUTICI S.P.A., Dompé farmaceutici S.p.A.
Severe Sjogren’s dry eye disease Sindrome dell'occhio secco di Sjögren grave, Severe Sjogren’s dry eye disease Sindrome dell'occhio secco di Sjögren grave, Diseases [C] - Eye Diseases [C11]
 
 
NGF0221 - PROTEGO-2, NCT05136170: Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease

Completed
3
85
Europe, US
Oxervate, Cenegermin, Vehicle, Placebo
Dompé Farmaceutici S.p.A
Dry Eye Syndrome
03/23
05/23
ADVISE, NCT03828019: Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

Active, not recruiting
3
222
Europe, Canada, US, RoW
Adalimumab (ADA), Adalimumab, Humira, Conventional immunosuppression (CON), Azathioprine, Imuran , Cyclosporine, Methotrexate, Rheumatrex, Mycophenolate, CellCept, Cyclosporine, Sandimmune, Neoral, Tacrolimus, Prograf
JHSPH Center for Clinical Trials
Uveitis
04/24
09/24
BOSTON-2, NCT03656926 / 2018-003205-25: Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant

Active, not recruiting
3
220
Europe, US, RoW
Liposomal Cyclosporine A, L-CsA, Standard of Care, SoC
Zambon SpA, BREATH Therapeutics Inc.
Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
03/24
10/24
BOSTON-1, NCT03657342 / 2018-003204-39: Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant

Active, not recruiting
3
220
Europe, US, RoW
Liposomal Cyclosporine A, L-CsA, standard of care, SoC
Zambon SpA, BREATH Therapeutics Inc.
Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
04/24
11/24
FANCY, NCT06658002: Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporin A

Not yet recruiting
3
150
US, RoW
Cyclosporine A, Placebo Comparator: Placebo
University of California, San Francisco, Aravind Eye Hospitals, India, Aravind Eye Care System
Fungal Keratitis, Corneal Ulcer
01/27
01/27
NCT04945096: Outcomes of Patients After Allo-HSCT With Decitabine and NAC

Not yet recruiting
3
100
NA
decitabine, 5-aza-2'-deoxycytidine, Acetylcysteine, Acetadote, Semustine, Methyl-CCNU, Cytarabine, Cytosine arabinoside, Busulfan, Myleran, Cyclophosphamide, Cytoxan, Cyclosporin A, Cyclosporine, Anti-thymocyte globulin, Thymoglobulin, Mycophenolate, CellCept
The First Affiliated Hospital of Soochow University
Engraft Failure, Relapse, GVHD
07/25
12/25
NCT04547049: A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Recruiting
3
160
RoW
Cytarabine, Busulfan, Cyclophosphamide, Me-CCNU, Rabbit antithymocyte globulin, Allogeneic HSCT, Cyclosporin A, Mycophenolate Mofetil, MTX
First Affiliated Hospital of Zhejiang University
Leukemia
09/25
12/25
NCT04877288 / 2018-000237-12: A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Recruiting
3
102
Europe, US
Belatacept, Nulojix, Tacrolimus, Cyclosporine A, Mycophenolate Mofetil, Enteric Coated Mycophenolate Sodium, Corticosteroids
Bristol-Myers Squibb
Renal Allograft Recipients
05/26
12/31
NCT04492891: Cyclosporine For The Treatment Of COVID-19(+)

Completed
2a
47
US
Cyclosporine, Neoral, Standard of Care Treatment
Bryan Burt, MD, Brigham and Women's Hospital
SARS (Disease)
12/21
12/21
NCT01469390: Pharmacodynamics, Efficacy, Safety of Basiliximab 40 or 80 mg Combined With CsA or Everolimus, in Low Risk de Novo Renal Transplant Recipients

Not yet recruiting
2
50
Europe
Basiliximab, Simulect
Novartis Pharmaceuticals
Renal Transplantation
04/13
 
2006-002031-24: The HAM Ciclosporin Study: An observational trial of therapy in early or progressing HAM/TSP

Ongoing
2
8
Europe
Ciclosporin, Ciclosporin, Neoral 10mg and 50mg soft gelatin capsules, Neoral 10mg and 50mg soft gelatin capsules
Imperial College
HTLV-I-associated myelopathy
 
 
2007-003672-19: NON APPLICABILE

Ongoing
2
40
Europe
CERTICAN, SANDIMMUN NEORAL, CERTICAN, SANDIMMUN NEORAL
AZIENDA OSPEDALIERA POLICLINICO DI MODENA
Immunosoppressive therapy in liver transplanted patients.
 
 
2012-002795-13: An early phase trial of Cyclosporin A in patients with early stage Chronic Lymphocytic Leukaemia (CLL) who do not currently require treatment.

Ongoing
2
10
Europe
Neoral Soft Gelatin Capsules, Ciclosporin A, Neoral Soft Gelatin Capsules, Neoral Soft Gelatin Capsules
University of Birmingham
Chronic Lymphocytic Leukaemia
 
 
ChiCTR-IIR-17012778: The mechanism of CDA-II improve blood of lower-risk myelodysplastic syndromes

Not yet recruiting
2
40
 
CDA-II ;cyclosporin a
Shanghai Jiao Tong University Affiliated Sixth People’s Hospital; Shanghai Jiao Tong University Affiliated Sixth People's Hospital, horizontal topic research
myelodysplastic syndromes
 
 
NCT00896493: Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Completed
2
38
US
anti-thymocyte globulin, ATG, cyclosporine, cyclosporin, cyclosporin A, Lymphoid radiation, Total lymphoid irradiation (TLI)
Stanford University
Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Bone Marrow Transplant Failure, Lymphoma, Non-Hodgkin, Cutaneous T-cell Lymphoma
11/21
12/22
NCT04328727: Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

Active, not recruiting
2
36
Japan, RoW
eltrombopag, ETB115, rabbit anti-thymocyte globulin (r-ATG), r-ATG, cyclosporine A (CsA), CsA
Novartis Pharmaceuticals
Severe Aplastic Anemia (SAA)
06/22
12/24
NCT01811368: Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Active, not recruiting
2
20
US
rituximab, IDEC-C2B8, Mabthera, Rituxan, ibritumomab tiuxetan, Zevalin, anti-thymocyte globulin, ATG, ATGAM, lymphocyte immune globulin, Thymoglobulin, total nodal irradiation, TLI, total lymphoid irradiation, peripheral blood stem cell transplantation, PBPC transplantation, PBSC transplantation, peripheral blood progenitor cell transplantation, transplantation, peripheral blood stem cell, allogeneic hematopoietic stem cell transplantation, cyclosporine, cyclosporin, cyclosporin A, CYSP, Sandimmune, mycophenolate mofetil, Cellcept, MMF
Joseph Tuscano, Spectrum Pharmaceuticals, Inc
Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma
04/23
12/23
NCT04644016: Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Recruiting
2
31
US
Clofarabine, Clolar, Fludarabine, Fludara, Busulfan, Busulfex, Cyclosporine-A, CSA, Mycophenolate Mofetil, MMF, Cord Blood Graft, CB graft
Memorial Sloan Kettering Cancer Center
AML, ALL, MDS, MPD Withou Myelofibrosis, NHL or HL, Inherited Metabolic Disorders, Hemoglobinopathies, Bone Marrow Failure, HLH
12/25
12/25
NCT00719888: Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

Active, not recruiting
2
135
US
Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Cyclosporine, 27-400, Ciclosporin, CsA, Cyclosporin, Cyclosporin A, Gengraf, Neoral, OL 27-400, Sandimmun, Sandimmune, SangCya, Double-Unit Umbilical Cord Blood Transplantation, Fludarabine, 118218, Fluorovidarabine, Laboratory Biomarker Analysis, Mycophenolate Mofetil, Cellcept, MMF, Total-Body Irradiation, Total Body Irradiation, Whole-Body Irradiation, SCT_TBI, TBI, Umbilical Cord Blood Transplantation, Cord Blood Transplantation, UCB transplantation, Thiotepa, 1,1',1"-phosphinothioylidynetrisaziridine, 1,1',1''-Phosphinothioyldynetrisaziridine, 52-24-4, 6396, Girostan, Triethylenethiophosphoramide, Triethylene Thiophosphoramide
Fred Hutchinson Cancer Center
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Burkitt Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Follicular Lymphoma, Lymphoblastic Lymphoma, Lymphoplasmacytic Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Non-Hodgkin Lymphoma, Plasma Cell Myeloma, Prolymphocytic Leukemia, Refractory Anemia, Small Lymphocytic Lymphoma
12/23
12/24
NCT04195633: Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Recruiting
2
60
US
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Cell Transplantation, Allogeneic Stem Cell Transplantation, HSC, HSCT, Stem Cell Transplantation, Allogeneic, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Cyclosporine, 27-400, Ciclosporin, CsA, Cyclosporin, Cyclosporin A, Cyclosporine Modified, Gengraf, Neoral, OL 27-400, Sandimmune, SangCya, Filgrastim, G-CSF, Neupogen, r-metHuG-CSF, Recombinant Methionyl Human Granulocyte Colony Stimulating Factor, rG-CSF, Tevagrastim, Filgrastim-aafi, Nivestym, Fludarabine, Fluradosa, Mycophenolate Mofetil, Cellcept, MMF, Mycophenolate Sodium, ERL 080, ERL 080A, Socium Mycophenolate, Total-Body Irradiation, TBI, Total Body Irradiation, Whole Body Irradiation, Whole-Body Irradiation, SCT_TBI, Treosulfan, 1,2,3, 4-Butanetetrol, 1,4-dimethanesulfonate, [R-(R*,S*)]-, Dihydroxybusulfan, Ovastat, Treosulphan, Tresulfon, Bone Marrow Aspiration, Bone Marrow Biopsy, Echocardiography, EC, Biospecimen Collection, Computed Tomography, CAT, CAT Scan, CT, CT Scan, Computerized Axial Tomography, Positron Emission Tomography, PET, PET scan
Fred Hutchinson Cancer Center, medac GmbH
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult Diffuse Large Cell Lymphoma, Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, Chronic Myeloid Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Hodgkin Lymphoma, Lymphoblastic Lymphoma, Lymphoplasmacytic Lymphoma, Mantle Cell Lymphoma, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Refractory Follicular Lymphoma, Refractory Marginal Zone Lymphoma, Refractory Small Lymphocytic Lymphoma
12/24
12/26
NCT01659606: Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

Active, not recruiting
2
40
Europe, US
alemtuzumab, Campath-1H, Fludarabine, Fludara, Cyclosporins, cyclosporine A, Neoral, Sandimmune, Mycophenolate mofetil, Cellcept, Tacrolimus, FK506, Prograf
Boston Children's Hospital, Dana-Farber Cancer Institute, Children's Hospital Medical Center, Cincinnati, Children's Hospital Los Angeles, Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Baylor College of Medicine, Children's Hospital of Philadelphia, University of Wisconsin, Madison, Karolinska University Hospital, Hackensack Meridian Health, Duke University, Oslo University Hospital, Children's Mercy Hospital Kansas City, Mayo Clinic, University of Chicago, Massachusetts General Hospital
Dyskeratosis Congenita, Hoyeraal Hreidarsson Syndrome, Revesz Syndrome, Aplastic Anemia
12/24
12/34
NCT06013423: Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Recruiting
2
54
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspirate, BONE MARROW, LIQUID, Human Bone Marrow Aspirate, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Asta B 518, B-518, WR-138719, Cyclosporine, 27-400, Ciclosporin, CsA, Cyclosporin, Cyclosporin A, Cyclosporine Modified, Gengraf, Neoral, OL 27-400, Sandimmune, SangCya, Diagnostic Imaging, Medical Imaging, Echocardiography, EC, Fludarabine Phosphate, 2-F-ara-AMP, 9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-.beta.-D-arabinofuranosyl)-, Beneflur, Fludara, SH T 586, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Mycophenolate Mofetil, CellCept, MMF, Survey Administration, Thiotepa, 1,1',1''-Phosphinothioylidynetrisaziridine, Girostan, N,N', N''-Triethylenethiophosphoramide, Oncotiotepa, STEPA, Tepadina, TESPA, Tespamin, Tespamine, Thio-Tepa, Thiofosfamide, Thiofozil, Thiophosphamide, Thiophosphoramide, Thiotef, Tifosyl, TIO TEF, Tio-tef, Triethylene Thiophosphoramide, Triethylenethiophosphoramide, Tris(1-aziridinyl)phosphine sulfide, TSPA, WR 45312, Total-Body Irradiation, SCT_TBI, TBI, Total Body Irradiation, Whole Body, Whole Body Irradiation, Whole-Body Irradiation, Umbilical Cord Blood Transplantation, Cord Blood, Cord Blood Transplantation, UCB transplantation, UMBILICAL CORD BLOOD TRANSPLANT
Fred Hutchinson Cancer Center, National Cord Blood Network
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Hematopoietic and Lymphoid System Neoplasm, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma, Chronic Myeloid Leukemia, BCR-ABL1 Positive
10/31
10/32
NCT05660785: Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia

Active, not recruiting
2
54
RoW
Herombopag, Cyclosporine A
Institute of Hematology & Blood Diseases Hospital, China, Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Non Severe Aplastic Anemia, Untreated
11/24
05/25
NCT04688021: A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Recruiting
2
46
RoW
Cytarabine, Busulfan, Cyclophosphamide, Me-CCNU, Rabbit antithymocyte globulin, Tocilizumab, Allogeneic HSCT, Cyclosporin A, Mycophenolate Mofetil, MTX
Yi Luo
Leukemia, Graft-versus-host-disease
12/24
12/24
NCT05323617: Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy

Withdrawn
2
40
NA
Romiplostim, Nplate®, Antithymocyte Globulin, Cyclosporine A
Amgen
Severe Aplastic Anemia (SAA)
02/25
02/25
NCT04530487: Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

Terminated
2
1
US
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Cell Transplantation, Allogeneic Stem Cell Transplantation, HSC, HSCT, Stem Cell Transplantation, Allogeneic, Cyclosporine, 27-400, Ciclosporin, CsA, Cyclosporin, Cyclosporin A, Cyclosporine Modified, Gengraf, Neoral, OL 27-400, Sandimmune, SangCya, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP-16, VP-16-213, VP16, Fludarabine Phosphate, 2-F-ara-AMP, 9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-.beta.-D-arabinofuranosyl)-, Beneflur, Fludara, SH T 586, Lapine T-Lymphocyte Immune Globulin, Anti-Thymocyte Globulin Rabbit, Grafalon, Rabbit Anti-Human Thymocyte Globulin (RATG), Rabbit Anti-Thymocyte Globulin, Rabbit Antithymocyte Globulin, Rabbit ATG, rATG, Thymoglobulin, Melphalan, Alanine Nitrogen Mustard, CB-3025, L-PAM, L-Phenylalanine Mustard, L-Sarcolysin, L-Sarcolysin Phenylalanine mustard, L-Sarcolysine, Melphalanum, Phenylalanine Mustard, Phenylalanine Nitrogen Mustard, Sarcoclorin, Sarkolysin, WR-19813, Mycophenolate Mofetil, CellCept, MMF, Tacrolimus, FK 506, Fujimycin, Hecoria, Prograf, Protopic, Thiotepa, 1,1'',1''''-Phosphinothioylidynetrisaziridine, Girostan, N,N'', N''''-Triethylenethiophosphoramide, Oncotiotepa, STEPA, Tepadina, TESPA, Tespamin, Tespamine, Thio-Tepa, Thiofosfamide, Thiofozil, Thiophosphamide, Thiophosphoramide, Thiotef, Tifosyl, TIO TEF, Tio-tef, Triethylene Thiophosphoramide, Triethylenethiophosphoramide, Tris(1-aziridinyl)phosphine sulfide, TSPA, WR 45312
M.D. Anderson Cancer Center
Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small Round Cell Tumor, Recurrent Malignant Peripheral Nerve Sheath Tumor, Recurrent Malignant Solid Neoplasm, Recurrent Neuroblastoma, Recurrent Rhabdomyosarcoma, Refractory Desmoplastic Small Round Cell Tumor, Refractory Malignant Peripheral Nerve Sheath Tumor, Refractory Malignant Solid Neoplasm, Refractory Neuroblastoma, Refractory Rhabdomyosarcoma
08/24
08/24
NCT01624805: Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

Recruiting
2
140
US
Anti-Thymocyte Globulin, Antithymocyte Globulin, Antithymocyte Serum, ATG, ATGAM, ATS, Thymoglobulin, Cyclosporine, 27-400, Ciclosporin, CsA, Cyclosporin, Cyclosporin A, Gengraf, Neoral, OL 27-400, Sandimmun, Sandimmune, SangCya, Filgrastim, FILGRASTIM, LICENSE HOLDER UNSPECIFIED, G-CSF, Neupogen, r-metHuG-CSF, Recombinant Methionyl Human Granulocyte Colony Stimulating Factor, rG-CSF, Tevagrastim, Methylprednisolone, Adlone, Caberdelta M, DepMedalone, Depo Moderin, Depo-Nisolone, Duralone, Emmetipi, Esametone, Firmacort, Medlone 21, Medrate, Medrol, Medrol Veriderm, Medrone, Mega-Star, Meprolone, Methylprednisolonum, Metilbetasone Solubile, Metrocort, Metypresol, Metysolon, Predni-M-Tablinen, Prednilen, Radilem, Sieropresol, Solpredone, Summicort, Urbason, Veriderm Medrol, Wyacort, Pegfilgrastim, Filgrastim SD-01, filgrastim-SD/01, Fulphila, HSP-130, Jinyouli, Neulasta, Neulastim, Pegfilgrastim Biosimilar HSP-130, SD-01, SD-01 sustained duration G-CSF
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome
06/26
06/26
NCI-2019-03188, NCT03970096: Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Recruiting
2
120
US
Total-Body Irradiation, Total Body Irradiation, Whole-Body Irradiation, TBI, Whole Body Irradiation, SCT_TBI, Total-Body Irradiation Prior to Stem Cell Transplant, Thiotepa, Oncotiotepa, STEPA, Tepadina, TESPA, Tespamin, Tespamine, Thio-Tepa, Thiofosfamide, Thiofozil, Thiophosphamide, Thiophosphoramide, Thiotef, Triethylene, Triethylenethiophosphoramide, SH-105, Fludarabine, Fluradosa, Tacrolimus, Prograf, Protopic, FK-506, Allogeneic CD34+-enriched and CD45RA-depleted PBSCs, Allogeneic TN-depleted CD34-preserved PBSCs, Allogeneic TND- CD34+ PBSCs, Donor-derived TN Cell Depleted CD34-enriched PBSCs, Naive T-cell Depleted CD34+ Allogeneic Peripheral Blood Stem Cells, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, Emthexat, Emtexate, Farmitrexat, Methotrexate LPF, Methylaminopterin, Methotrexatum, Metotrexato, Cyclophosphamide, Ciclofosfamida, Ciclofosfamide, Cicloxal, Claphene, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cytophosphan, Asta B 518, WR-138719, Peripheral Blood Stem Cell, PBSC, Peripheral Blood Stem Cells, peripheral stem cell, Peripheral Stem Cells, Cyclosporine, Ciclosporin, CsA, Cyclosporin, Cyclosporin A, Cyclosporine Modified, Gengraf, Neoral, Sandimmune, SangCya, Sirolimus, RAPA, Rapamune, rapamycin, SILA 9268A, WY-090217, Busulfan, Bussulfam, Busulfanum, Busulphan, Busulfex, CB 2041, Glyzophrol, Joacamine, Methanesulfonic Acid Tetramethylene Ester, Mielucin, Misulban, Misulfan, Mitosan, Myeleukon, Myeloleukon, Myelosan, Mylecytan, Myleran, Sulfabutin, Tetramethylene Bis(methanesulfonate), Tetramethylene bis[methanesulfonate], WR-19508, Bone Marrow Aspiration and Biopsy, Echocardiography, EC, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Biospecimen Collection
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm
12/26
12/28
CIT, NCT05946772: Cyclosporine In Takotsubo Syndrome

Not yet recruiting
2
204
Europe
Cyclosporine A, Placebo
University Hospital Heidelberg, German Centre of Cardiovascular Research (DZHK), Coordinating Centre for Clinical Studies (KKS) Heidelberg
Takotsubo Cardiomyopathy
10/26
10/27
NCI-2017-01311, NCT03246906: Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Active, not recruiting
2
150
US
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Cell Transplantation, Allogeneic Stem Cell Transplantation, HSC, HSCT, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Cyclosporine, 27-400, Ciclosporin, CsA, Cyclosporin, Cyclosporin A, Gengraf, Neoral, OL 27-400, Sandimmun, Sandimmune, SangCya, Mycophenolate Mofetil, Cellcept, MMF, Sirolimus, AY 22989, RAPA, Rapamune, Rapamycin, SILA 9268A, WY-090217
Fred Hutchinson Cancer Center, National Cancer Institute (NCI), National Institutes of Health (NIH)
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm, Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Recurrent Waldenstrom Macroglobulinemia, Hematologic and Lymphocytic Disorder, Blastic Plasmacytoid Dendritic Cell Neoplasm
05/25
05/25
NCT04540926: Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia

Not yet recruiting
1/2
200
RoW
Cyclosporin A
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
COVID 19 Pneumonia
09/20
09/20
NCT01033552: Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs

Completed
1/2
32
US
Cyclophosphamide, Cytoxan, Fludarabine, Fludara, Anti-thymocyte globulin, ATG, Myeloablative Busulfan, Mesenchymal stem cell transplantation, MSCT, Total body irradiation, Bone marrow or umbilical cord blood (UCG) stem cell transplantation, UCBSCT
Masonic Cancer Center, University of Minnesota
Epidermolysis Bullosa
08/21
08/21
NCT05794425: Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders

Recruiting
1/2
100
RoW
Cyclosporine A, Umbilical cord blood & Umbilical cord derived mesenchymal stem cells
Shandong Qilu Stem Cells Engineering Co., Ltd., Shandong Provincial Third Hospital, Dezhou People's Hospital, Children's Hospital Affiliated to Shandong University, The Second Affiliated Hospital of Shandong First Medical University, Tai'an Central Hospital, Linyi People's Hospital, Linyi Central Hospital, Rizhao People's Hospital, Lanling People's Hospital, Shandong Jining No.1 People's Hospital, The affiliated hospital of Jining medical college, Zibo municipal hospital, Binzhou People's Hospital, The Affiliated Hospital of Binzhou Medical College, Shengli Oilfield Central Hospital, Weihai Municipal Hospital, Weihai Central Hospital, The Second Affiliated Hospital of Shandong University of traditional Chinese Medicine, Gansu Provincial Hospital of Traditional Chinese Medicine (TCM), Wuwei People's Hospital, Gansu Wuwei Tumour Hospital, The Second Affiliated Hospital of Harbin Medical University, Yuncheng Institute of Hematology, Kaifeng Central Hospital, Zhengzhou Central Hospital, Air Force Hospital of Western War Zone, The First People' s Hospital of Yunnan Province, Zigong No.1 Peoples Hospital, The First People's Hospital of Jingzhou, Jiangxi Province Children's Hospital, Second Affiliated Hospital of Zhengzhou University, Shandong University of Traditional Chinese Medicine, Yantai Ludong Hospital (Shandong Provincial Hospital Group)
Bone Marrow Failure Disorders
04/25
04/26
NCT03128034: 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Suspended
1/2
75
US
Cyclosporine, 27-400, Ciclosporin, CsA, Cyclosporin, Cyclosporin A, Gengraf, Neoral, OL 27-400, Sandimmun, Sandimmune, SangCya, Fludarabine Phosphate, 2-F-ara-AMP, 9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-.beta.-D-arabinofuranosyl)-, Beneflur, Fludara, SH T 586, Laboratory Biomarker Analysis, Mycophenolate Mofetil, Cellcept, MMF, Peripheral Blood Stem Cell Transplantation, PBPC transplantation, PBSCT, Peripheral Blood Progenitor Cell Transplantation, Peripheral Stem Cell Support, Peripheral Stem Cell Transplant, Peripheral Stem Cell Transplantation, Pharmacological Study, Pretargeted Radioimmunotherapy, Total-Body Irradiation, Total Body Irradiation, Whole-Body Irradiation, TBI, Whole Body Irradiation, SCT_TBI
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome With Excess Blasts, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Refractory Acute Myeloid Leukemia, Refractory Mixed Phenotype Acute Leukemia, Mixed Phenotype Acute Leukemia
01/23
03/27
NCT02188264: Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer

Active, not recruiting
1
40
Canada, US
Cyclosporine, 27-400, Ciclosporin, CsA, CyA, Cyclosporin, Cyclosporin A, Cyclosporine Modified, Gengraf, Neoral, OL 27-400, Sandimmune, SangCya, Laboratory Biomarker Analysis, Pharmacological Study, Selumetinib, ARRY-142886, AZD 6244, AZD-6244, AZD6244, MEK Inhibitor AZD6244
National Cancer Institute (NCI)
Recurrent Colorectal Carcinoma, Solid Neoplasm, Stage IIIA Colorectal Cancer AJCC v7, Stage IIIB Colorectal Cancer AJCC v7, Stage IIIC Colorectal Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7
01/17
03/25
NCT02867800: Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease

Completed
1
24
US
Diphenhydramine, Benadryl, Acetaminophen, Tylenol, Methylprednisolone, Medrol, Meperidine, Demerol, Alemtuzumab, Lemtrada, Thymoglobulin, Genzyme, Fludarabine, Fludara, Melphalan, Alkeran, Thiotepa, Thioplex, Cyclosporine, Neoral, Tacrolimus, Protopic, Methotrexate, Trexall, Abatacept, CTLA4-Ig, Orencia, Marrow infusion, stem cell transplant, Sirolimus, Rapamune, Mycophenolate Mofetil, MMF
Monica Bhatia
Sickle Cell Disease, Graft Versus Host Disease
12/21
12/23
NCT03013933: Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Completed
1
29
US
Brentuximab Vedotin, ADC SGN-35, Adcetris, Anti-CD30 Antibody-Drug Conjugate SGN-35, Anti-CD30 Monoclonal Antibody-MMAE SGN-35, Anti-CD30 Monoclonal Antibody-Monomethylauristatin E SGN-35, cAC10-vcMMAE, SGN-35, Cyclosporine, 27-400, Ciclosporin, CsA, Cyclosporin, Cyclosporin A, Cyclosporine Modified, Gengraf, Neoral, OL 27-400, Sandimmune, SangCya, Pharmacokinetic Study, PHARMACOKINETIC, PK Study, Verapamil, Verapamil Hydrochloride, (+-)-Verapamil hydrochloride, Calan, Isoptin SR, Verelan
City of Hope Medical Center, National Cancer Institute (NCI)
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma
05/22
05/22
NCT04375631: CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Recruiting
1
120
US
Cladribine, 2-CdA, 2CDA, CdA, Cladribina, Leustat, Leustatin, Leustatine, RWJ-26251, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Cyclosporine, 27-400, Ciclosporin, CsA, Cyclosporin, Cyclosporin A, Cyclosporine Modified, Gengraf, Neoral, OL 27-400, Sandimmune, SangCya, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Filgrastim, G-CSF, Neupogen, r-metHuG-CSF, Recombinant Methionyl Human Granulocyte Colony Stimulating Factor, rG-CSF, Tevagrastim, Nivestym, Filgrastim-aafi, Filgrastim-ayow, Releuko, Hematopoietic Cell Transplantation, HCT, Hematopoietic Stem Cell Transplantation, HSCT, Stem Cell Transplant, stem cell transplantation, Hematopoietic Stem Cell Infusion, Mitoxantrone, Dihydroxyanthracenedione, Mitozantrone, Mycophenolate Mofetil, Cellcept, MMF, Mycophenolate Sodium, ERL 080, ERL 080A, Socium Mycophenolate, Total-Body Irradiation, TBI, Total Body Irradiation, Whole Body Irradiation, Whole-Body Irradiation, SCT_TBI, Idarubicin, 4-DMDR, Fludarabine, Fluradosa, 9-Beta-D-arabinofuranosyl-2-fluoroadenine, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Echocardiography, EC, X-Ray Imaging, Conventional X-Ray, Diagnostic Radiology, Medical Imaging, Bone Marrow Biopsy, Bone Marrow Aspiration
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia, Refractory Chronic Myelomonocytic Leukemia, Refractory Mixed Phenotype Acute Leukemia, Refractory Myelodysplastic Syndrome, Refractory Acute Leukemia of Ambiguous Lineage, Refractory Acute Undifferentiated Leukemia
12/25
12/27
NCT06246786: Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)

Recruiting
1
24
US
Cyclosporin A, CsA
Virginia G. Kaklamani
Triple Negative Breast Cancer, DNA Damage Repair Deficiency
07/26
07/27
ChiCTR2100048572: Application of cyclosporin A in patients with unexplained repeated implantation failure in embryo transfer

Not yet recruiting
N/A
200
 
application with cyclosporin A ;No
Sichuan Provincial Hospital for Woman and Children; Sichuan Provincial Hospital For Woman and Children, None
unexplained repeated implantation failure
 
 
ChiCTR-ONC-12002181: Associations of CYP3A and ABCB1 Polymorphisms with Pharmacokinetics of Cyclosporine A in Early Renal Recipients after Transplantation

Completed
N/A
126
 
after renal transplantation
Institute of Clinical Pharmacology, Central South University; Institute of Clinical Pharmacology, Central South University, Major National Funding for Drug Discovery, National Natural Science Foundation
Renal Transplantation
 
 
ChiCTR-TRC-13003204: The multicentre, prospective, controlled study on the effection and safety of individualizing immunosuppresive program according to cytochrome P450(CYP) 3A5 gene polymorphism in liver transplant patients

Completed
N/A
100
 
FK506 ;cyclosporine A
Beijing You'An Hospital, Capital Medical University; Beijing You'An Hospital, Capital Medical University, The Ministry of health organ transplantation research project
liver transplantation
 
 
ChiCTR-INR-16009363: 'Yu Xue Qi Huo' theory based integrated Traditional Chinese and Western Medicine in the diagnosis and treatment of stratified relapsed and refractory primary immune thrombocytopenia

Recruiting
N/A
400
 
Yangyin Traditional Chinese Medicine: brew the TCM granules in warm water, 1 pack bid p.o. 1 hour after meal for 6 months continuously ;Cyclosporin A capsules: 5mg/kg/d p.o., adjusted according to the serum CsA concentration ;Traditional Chinese Medicine for control group ;Cyclosporin A capsules: 5mg/kg/d p.o., adjusted according to the serum CsA concentration ;Yangyin Traditional Chinese Medicine: brew the TCM granules in warm water, 1 pack bid p.o. 1 hour after meal for 6 months continuously ;rhTPO: 1ug/kg/d qd for 14 days continuously, ih, until platelet count reaches 100×10^9/L ;Traditional Chinese Medicine for control group ;rhTPO: 1ug/kg/d qd for 14 days continuously, ih, until platelet count reaches 100×10^9/L
Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine; Rui Jin hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai Municipal Commission of Health and Family Planning, Office of Development of Shanghai Traditional Chinese Medicine
Immune Thrombocytopenia
 
 
ChiCTR-OON-17014165: A clinical trial to evaluate the efficacy and safety of corticosteroids combined with cyclosporin A in the treatment of primary immune thrombocytopenia

Recruiting
N/A
200
 
Corticosteroids ;Corticosteroids combined with Cyclosporin A
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology; Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, self-financing
Immune Thrombocytopenia
 
 
ChiCTR2000034702: Retrospective analysis of the relationship between cyclosporine A trough concentration and GVHD incidence in children and prognosis after hematopoietic stem cell transplantation

Not yet recruiting
N/A
60
 
Nil
Hebei Yanda Lu Daopei Hospital; Hebei Yanda Lu Daopei Hospital, N/A
hematopoietic stem cell transplantation
 
 
ChiCTR-INR-17013144: Efficacy of etoposide in Conventional Treatment–Refractory Adult-Onset Still's Disease

Recruiting
N/A
40
 
Etoposide ;cyclosporin a
Department of Rheumatology, Renji Hospital South Campus, School of Medicine, Shanghai JiaoTong University; Department of Rheumatology, Renji Hospital South Campus, School of Medicine, Shanghai JiaoTong University, , self-financing
Adult-Onset Still's Disease
 
 
ChiCTR1800017532: Anti-scarring study after glaucoma surgery

Recruiting
N/A
40
 
Cyclosporine A eye drops 3 days before and 3months after glaucoma surgery ;Subconjunctiva injection of conbercept during glaucoma surgery
Eye and ENT Hospital of Fudan University; Eye and ENT Hospital of Fudan University, Self-funding
glaucoma
 
 
ChiCTR2000031094: Effect of cyclosporine A on Th1/ Th2 cytokines expression and pregnancy outcome in patients with immune repeated implantation failure

Not yet recruiting
N/A
90
 
cyclosporine A ;No ;No
Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University; Qilu Hospital of Shandong University, Departmental funding (support ourself)
repeated implantation failure
 
 
NCT04705584: Topical Immuonosuppressant Drugs in Spring Catarrh

Not yet recruiting
N/A
180
RoW
Prednisolone (as Acetate), Predforte Eye drops, CycloSPORINE Ophthalmic Suspension, LTacrolimus Topical
Assiut University
Vernal Keratoconjunctivitis
10/21
02/22
OnceDaily, NCT02426502: Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients

Active, not recruiting
N/A
76
Canada
Conversion to Advagraf, Prograf, Cyclosporine (Neoral), Advagraf, conversion of non-immunosuppressant drugs to once daily, anti-hypertensive medications, non-immunosuppressant drugs, Conversion to once daily MPA, Mycophenolate Mofetil, Myfortic, Azathioprine, Prednisone
University of British Columbia, Astellas Pharma Canada, Inc.
End-Stage Renal Disease
08/22
12/24
NCT06512766: a Retrospective Study on the Systemic Treatment of LPP and FFA

Completed
N/A
315
Europe
Hydroxychloroquine, Methotrexate, Cyclosporine A, Retinoids
Erasmus Medical Center
Cicatricial Alopecia, Lichen Planopilaris, Lichen Plano-Pilaris, Frontal Fibrosing Alopecia, Hair Diseases, Scarring Alopecia, Hair Loss/Baldness
02/23
02/23
ChiCTR1900027753: Efficacy and safety of cyclosporine and azathioprine in patients with refractory ITP

Not yet recruiting
N/A
90
 
Using cyclosporine A for treatment ;Using azathioprine for treatment ;Treatment with glucocorticoids
the Second Affiliated Hospital of Kunming Medical University; the Second Affiliated Hospital of Kunming Medical University, the Second Affiliated Hospital of Kunming Medical University
Primary Immune Thrombocytopenia
 
 
 

Download Options